Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA Voices

FDA Voices Home
          News & Events
          FDA Newsroom
          FDA Voices
          Equivalence: Using a Trade Mechanism to Ensure Broader Consumer Choice and Open New Markets for Molluscan ShellfishFDA Voices Equivalence: Using a Trade Mechanism to Ensure Broader Consumer Choice and Open New Markets for Molluscan Shellfish
  
  	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintImage
              collage of three photos featuring closeups of oysters and clams and wide shot of an FDA inspector overseeing a person sorting harvested oysters*By: Mark Abdoo, Associate Commissioner, Global Policy and Strategy, and Susan Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition*

For the first time, the U.S. Food and Drug Administration is using a mechanism known as equivalence to begin reopening markets in raw and processed molluscan shellfish that have been closed to trade between the United States and the European Union (EU) since 2010.

FDA Acting Deputy Commissioner for Global Regulatory Operations and Policy,  Mark Abdoo
Mark AbdooUnderstanding the food safety issues surrounding molluscan shellfish helps to explain the significance of the equivalence determination, and why this trade mechanism goes hand-in-hand with strong food safety protections.

Molluscan bivalve shellfish – such as oysters, clams, mussels and roe-on and whole scallops – are considered good sources of quality protein and are eaten either raw or processed. As filter feeders, molluscs take nourishment by filtering water containing plankton and food particles through their gills, which raises the importance of the safety of the water through which they eat. The U.S. shellfish industry follows a variety of rigorous food safety steps both during and after harvest to ensure the safety of its product and the FDA has specific procedures in place to ensure compliance.

As a leader in food safety standards, the FDA has a variety of import controls to ensure that food coming from outside of the United States is safe for American consumers. The FDA stopped accepting raw shellfish imported from EU countries in the 1980s due to public health concerns. In 2010, the EU, which uses different safety controls for several aspects of their food control system, stopped accepting U.S. exports of raw bivalve molluscan shellfish after the European Commission (EC) conducted an audit and determined that the U.S. food safety controls were different from and did not comply with comparable EU requirements.

In an effort to resume molluscan shellfish trade, the FDA and the EC decided to independently assess each other’s food safety controls for molluscan shellfish using an approach spelled out in the Veterinary Equivalency Agreement signed by the U.S. and the EU in 1999. Article 4 of the 1995 World Trade Organization Agreement on the Application of Sanitary and Phytosanitary Measures provides a mechanism for facilitating trade between member countries that use different food safety control measures to achieve at least the same level of public health protection.

Beginning in 2010, the FDA initiated an equivalence assessment of the EU food safety system for raw molluscan shellfish to see if the food safety measures, as specifically implemented in Spain and the Netherlands, provide at least the same level of safety protection as comparable measures in the United States. Separately, the EC initiated an assessment of the U.S. system.

The FDA’s efforts culminated in a proposed equivalence determination published in the Federal Register in 2018. The proposal would initially be limited to shellfish harvested from specified growing areas in Spain and the Netherlands, which would be required to implement additional controls for raw molluscan shellfish exported to the United States.

Photo of Susan T. Mayne, Ph.D.
Susan T. Mayne, Ph.D.Around the same time, the EU’s food safety regulatory authority separately determined the U.S. food safety control system for raw and processed molluscan shellfish to be equivalent to the EU system and would begin by accepting shellfish from certain growing areas in Massachusetts and Washington.

In addition to the FDA announcing a final equivalence determination today, since 2018, the FDA and the EU have been working out implementation details that will open the door for trade in raw molluscan shellfish. Although Spain and the Netherlands in the EU and Massachusetts and Washington in the United States will be the first participants, arrangements have been made to use a streamlined process for expanding market access between these two trading partners.

Fish products account for more than $5 billion in total value of U.S. exports, and roughly one-third of that is shellfish. With a 6 percent share of global trade, the United States is the sixth-largest supplier of fish and seafood products to the world market. Moreover, American businesses have seen a steady growth in seafood exports over the last decade with one of the largest export markets being the EU, suggesting that today’s determination will help to unlock economic opportunity by creating a path forward to new market access for U.S. exporters. At the same time, today’s final determination will ensure there is a wider selection of healthy and safe seafood options available to the American consumer from countries in Europe.

                                                                                  Content current as of:
      09/23/2020
              
              
Regulated Product(s)
		 Food & BeveragesFDA Voices
 FDA Voices Email
                        Subscribe to receive FDA Voices email notifications.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop